EQRx to Participate in Cowen’s 42nd Annual Health Care Conference
03 March 2022 - 12:00AM
EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company
committed to developing and delivering innovative medicines to
patients at radically lower prices, today announced that management
will participate in a fireside chat at Cowen’s 42nd Annual Health
Care Conference on Wednesday, March 9, 2022 at 12:50 p.m. ET.
A live and archived webcast of the fireside chat will be
available by visiting the Events & Presentations section of
EQRx’s website at investors.eqrx.com.
About EQRxEQRx is a new type of pharmaceutical
company committed to developing and delivering innovative medicines
to patients at radically lower prices. Launched in January 2020,
EQRx is purpose-built, at scale, with a growing catalog of
medicines in development in high-cost drug categories and emerging
partnerships with leading payers and providers. Leveraging
cutting-edge science and technology and strategic partnerships with
stakeholders from across the healthcare system, EQRx aims to
provide innovative, patent-protected medicines more efficiently and
cost-effectively than ever before. To learn more, visit
www.eqrx.com and follow us on social media:
Twitter: @EQRxInc, LinkedIn,
Instagram: @eqrxinc.
EQRx™ and Remaking Medicine™ are trademarks of EQRx.
EQRx Contacts:
Media:Dan Budwick1ABdan@1abmedia.com
Investors:investors@eqrx.com
EQRx (NASDAQ:EQRX)
Historical Stock Chart
From Apr 2024 to May 2024
EQRx (NASDAQ:EQRX)
Historical Stock Chart
From May 2023 to May 2024